PLOS is a nonprofit open-access science, technology, and medicine publisher with a library of open-access journals and other scientific literature under an open-content license. It launched its first journal, PLOS Biology, in October 2003 and publishes seven journals. The organization is based in San Francisco, California, and has a European editorial office in Cambridge, England. The publications are primarily funded by payments from the authors.
BioMed Central (BMC) is a United Kingdom-based, for-profit scientific open access publisher that produces over 250 scientific journals. All its journals are published online only. BioMed Central describes itself as the first and largest open access science publisher. It was founded in 2000 and has been owned by Springer, now Springer Nature, since 2008.
The Institute for Scientific Information (ISI) was an academic publishing service, founded by Eugene Garfield in Philadelphia in 1956. ISI offered scientometric and bibliographic database services. Its specialty was citation indexing and analysis, a field pioneered by Garfield.
Springer Science+Business Media, commonly known as Springer, is a German multinational publishing company of books, e-books and peer-reviewed journals in science, humanities, technical and medical (STM) publishing.
Nature Reviews Nephrology is a monthly peer-reviewed review journal published by Nature Portfolio. It was established as Nature Clinical Practice Nephrology in 2005, but change name in 2009. The editor-in-chief is Susan Allison.
PLOS Genetics is a peer-reviewed open access scientific journal established in 2005 and published by the Public Library of Science. The founding editor-in-chief was Wayne N. Frankel. The current editors-in-chief are Gregory S. Barsh and Gregory P. Copenhaver. The journal covers research on all aspects of genetics and genomics.
The British Journal of Cancer is a twice-monthly professional medical journal owned by Cancer Research UK, published on their behalf by Springer Nature's Nature Research.
The European Journal of Human Genetics is a monthly peer-reviewed scientific journal published by the Nature Publishing Group on behalf of the European Society of Human Genetics. It covers all aspects of human genetics.
The American College of Medical Genetics and Genomics (ACMG) is an organization composed of biochemical, clinical, cytogenetic, medical and molecular geneticists, genetic counselors and other health care professionals committed to the practice of medical genetics.
The Postgraduate Medical Journal is a monthly peer-reviewed medical journal that was established in 1925 by the Fellowship of Postgraduate Medicine, of which it is the official journal. It is currently published on behalf of the Fellowship by the BMJ Group.
The International Journal of Obesity is a peer-reviewed medical journal published by the Nature Publishing Group. It was established in 1977 as International Journal of Obesity by Newman Pub. in collaboration with the Association for the Study of Obesity and the North American Association for the Study of Obesity. In 1992, the journal change its name to International Journal of Obesity and Related Metabolic Disorders upon acquisition by the Nature Publishing Group. In 2005, the journal returned to its original name.
Archives of Disease in Childhood is a peer-reviewed medical journal published by the BMJ Group and covering the field of paediatrics. It is the official journal of the Royal College of Paediatrics and Child Health.
Bruce Richard Korf is a medical geneticist at the University of Alabama at Birmingham. In April 2009, he began a two-year term as president of the American College of Medical Genetics (ACMG), a professional organization.
Nature Communications is a peer-reviewed, open access, scientific journal published by Nature Portfolio since 2010. It is a multidisciplinary journal and it covers the natural sciences, including physics, chemistry, earth sciences, medicine, and biology. The founding editor-in-chief was Lesley Anson, followed by Joerg Heber, Magdalena Skipper, and Elisa De Ranieri. The journal has editorial offices in London, Berlin, New York City, and Shanghai.
Pathogens and Global Health is a peer-reviewed medical journal published by Taylor & Francis. It covers tropical diseases, including their microbiology, epidemiology and molecular biology, as well as medical entomology, HIV/AIDS, malaria, and tuberculosis. The editor-in-chief is Andrea Crisanti.
Frontiers Media SA is a publisher of peer-reviewed open access scientific journals currently active in science, technology, and medicine. It was founded in 2007 by Kamila Markram and Henry Markram, and later expanded to other academic fields. Frontiers is based in Lausanne, Switzerland, with other offices in London, Madrid, Seattle and Brussels. In 2022, Frontiers employed more than 1,400 people, across 14 countries. All Frontiers journals are published under a Creative Commons Attribution License.
eLife is a not-for-profit, peer-reviewed, open access, scientific journal for the biomedical and life sciences. It was established at the end of 2012 by the Howard Hughes Medical Institute, Max Planck Society, and Wellcome Trust, following a workshop held in 2010 at the Janelia Farm Research Campus. Together, these organizations provided the initial funding to support the business and publishing operations. In 2016, the organizations committed US$26 million to continue publication of the journal.
Homeopathy is a peer-reviewed medical journal covering research, reviews, and debates on all aspects of homeopathy, a pseudoscientific form of alternative medicine. It is the official journal of the London-based Faculty of Homeopathy. The journal was established in 1911 as the British Homoeopathic Journal, resulting from a merger between the British Homoeopathic Review and the Journal of the British Homoeopathic Society. It obtained its current name in 2001 and the Editor-in-chief is Dr Robert Mathie. The journal was originally published by Nature Publishing Group, and was then published by Elsevier. Elsevier's decision to publish this journal has been called into question, given homeopathy's proven ineffectiveness and unscientific status. Elsevier's Vice President of Global Corporate Relations, Thomas Reller, has defended Elsevier's decision to publish the journal, saying that "We support debate around this topic". The journal has been published by Thieme Medical Publishers since 2018.
Experimental & Molecular Medicine is a monthly peer-reviewed open access medical journal covering biochemistry and molecular biology. It was established in 1964 as the Korean Journal of Biochemistry or Taehan Saenghwa Hakhoe Chapchi and published bi-annually. It was originally in Korean becoming an English-language journal in 1975. In 1994 the journal began publishing quarterly. It obtained its current name in 1996 at which time it also began publishing bi-monthly, switching to monthly in 2009. It is the official journal of the Korean Society for Medical Biochemistry and Molecular Biology. The editor-in-chief is Dae-Myung Jue. It is published by the Nature Publishing Group. The full text of the journal from 2008 to the present is available at PubMed Central.
A variant of uncertainsignificance (VUS) is a genetic variant that has been identified through genetic testing but whose significance to the function or health of an organism is not known. Two related terms are "gene of uncertain significance" (GUS), which refers to a gene that has been identified through genome sequencing but whose connection to a human disease has not been established, and "insignificant mutation", referring to a gene variant that has no impact on the health or function of an organism. The term "variant' is favored in clinical practice over "mutation" because it can be used to describe an allele more precisely. When the variant has no impact on health, it is called a "benign variant". When it is associated with a disease, it is called a "pathogenic variant". A "pharmacogenomic variant" has an effect only when an individual takes a particular drug and therefore is neither benign nor pathogenic.
